The industry conference highlighted how new technology can be used to solve vexing, expensive and work-intensive problems.

Manny Krakaris, CEO of Augmedix, said he supports the WHO’s advisory. “This is a quickly evolving topic and using caution is paramount to patient safety and privacy.”

While ChatGPT grabs the headlines, there are other uses of artificial intelligence that can support clinicians and aid value-based care efforts.

Publicly-traded Augmedix (market cap: $109 million) has raised $12 million in strategic financing from HCA Healthcare and Redmile Group to advance its ambient artificial intelligence software…

A deep dive into the HCA Healthcare-Augmedix partnership announcement with Ian Shakil, Augmedix Founder.

Hospital giant HCA Healthcare is deploying artificial intelligence-enabled medical dictation software in partnership with healthcare tech company Augmedix, the two organizations said Thursday.

Nashville, Tenn.-based HCA Healthcare is partnering with medtech company Augmedix to expand the use of artificial intelligence-powered ambient documentation in its clinical settings.

Large hospital chain also is making a financial investment in Augmedix to accelerate progress in Augmedix’s artificial intelligence research efforts.

Speaking of clinical AI: HCA, one of the country’s largest hospital systems, is investing $12 million in the AI-powered medical scribe company Augmedix to help speed the development and commercialization of its product for HCA’s use. 

Thoughts on AI’s foray into healthcare and clinical workflow, including opportunity spaces for AI applications in clinical workflow and a segmentation of the current space and the competition dynamics between players.